AI Chatbot Use Linked to Higher Belief in Vaccine Myths, KFF Poll Finds Frequent users of AI chatbots are more likely to believe anti-vaccine myths, according to a poll by …
COVID-19
-
-
Remdesivir, sold under the brand name Veklury, is an antiviral medication approved by the U.S. Food and Drug Administration (FDA) to treat COVID-19 in certain adults and pediatric patients. It …
-
Single-Shot Vaccine Under Development Could Protect Against Flu, COVID-19, and RSV A single-shot vaccine targeting influenza, COVID-19, and respiratory syncytial virus (RSV) is being developed by researchers, aiming to address …
-
A Nationwide Chilean Cohort Study Links Severe COVID-19 to Increased Risk of Chronic Health Conditions A nationwide Chilean cohort study of 3.6 million adults found that severe COVID-19 requiring hospitalization …
-
The Future of mRNA Technology Beyond COVID-19 Vaccines Messenger RNA (mRNA) technology, popularized by the rapid development of COVID-19 vaccines, is currently being adapted to target a wide range of …
-
Remdesivir, branded as Veklury, was the first antiviral medication approved by the U.S. Food and Drug Administration (FDA) to treat COVID-19 in patients requiring hospitalization. While clinical trials established its …
-
Precious Bland Legal Case: Insanity Defense Amidst COVID-19 Claims The legal case against Precious Bland, a mother accused of causing her infant’s death, has sparked debate over the use of …
-
Remdesivir for COVID-19: Clinical Efficacy and Current Guidelines Remdesivir, marketed as Veklury, is an antiviral medication administered intravenously to treat COVID-19 in specific patient populations. According to the National Institutes …
-
Vermont’s COVID-19 Reopening: A Look Back at the June 2021 Transition On June 14, 2021, Vermont Governor Phil Scott officially lifted the state’s remaining COVID-19 safety restrictions, marking the end …
-
Israeli and Czech scientists recreate COVID-19’s evolutionary pathway in lab study Israeli and Czech researchers have successfully reconstructed the evolutionary trajectory of SARS-CoV-2 in a laboratory setting, according to a …